Saturday, August 19, 2017
Yesterday Catasys reported their second quarter earnings. The report itself wasn't overly impressive as, despite high year over year growth, numbers dropped slightly from the first quarter. This, however, was not unexpected by the market, as the Company has...
Tailwinds' Take: Growth in eligible members in July, going up to 24,000, suggests that the company is on track for internal forecasts of around $50M in billings in 2018. Q3 numbers will confirm whether this is true or not,...
Tailwinds' Take: HCSC and Anthem are the two largest Blues. Per company guidance, one could reasonably expect both of them to be clients by year end. They represent 50% of all the Blue business, so this story is just...
Tailwinds' Take: CATS is at an inflection point in their business. Per these quotes, "The Company expects to see enrollment totals through this contract increase considerably starting in the third quarter of 2017...Our next step will be to launch...
In March of 2017, Catasys (CATS) reported their fourth quarter results for 2016. This was an important earnings announcement as it marked the first quarter of the product launching with major health plans, which resulted in a large uptick...
On June 27, 2017, Catasys' CEO Terren Peizer spoke with Tailwinds partner Daniel Carlson, discussing the current business of CATS, the growth plans, and the competitive landscape. Tailwinds has a $16.20 target on CATS and it's a member of...
On June 21st, 2017, Tailwinds initiated coverage of Catasys, Inc.
As of this morning, at a price of $4.03, we added Catays, Inc. (CATS) to our portfolio. Catasys leads the health care industry in improving health and reducing claims costs for health plan members with behavioral health (BH) disorders that...
Los Angeles, California—June 1, 2017—Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health insurance plans, announced today that it is now receiving all of the member data expected from a leading national...
Los Angeles, California—May 24, 2017—Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health insurance plans, announced today that it has launched enrollment under the previously announced contract for its OnTrak™-C solution coverage...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address